Oak Street Health and Interwell Health announced the launch of OakWell, a joint venture that will offer the highest-quality primary care to end-stage kidney disease (ESKD) patients directly in the dialysis center. This unique approach to primary care for ESKD patients aims to reduce hospitalizations, increase kidney transplantations, and improve outcomes to lower the total cost of care. When a patient receives in-center dialysis treatment, they spend around 12 hours each week in a dialysis center, often making it difficult to attend primary care and other healthcare appointments.

This is a significant challenge, as dialysis patients often have other complex chronic conditions and would benefit from high-quality, preventive primary care. OakWell will bring the type of coordinated primary care that dialysis patients need directly to them, offering appropriate interventions in the center while still working in close partnership with nephrologists. The OakWell care teams will closely manage patients' chronic conditions, help them avoid missed dialysis treatments, quickly reschedule any missed dialysis treatments, and coordinate care outside of the center.

When patients have urgent needs and aren't currently in a dialysis center, providers will conduct video visits and provide other support to make sure patients stay healthy and out of the hospital. Additional services such as behavioral health and renal pharmacy support will provide complete, wraparound care. OakWell care teams will also support coordination of kidney transplants when possible.

OakWell will initially begin offering care services in Chicago, Houston and Dallas-Fort Worth dialysis centers in third quarter of 2023.